Q99.0
Chimera 46, XX/46, XY
Clinical Classification Guidelines
Inclusion Terms
- Chimera 46, XX/46, XY true hermaphrodite
Medical Intelligence & Overview
Chimera 46, XX/46, XY is a rare genetic condition where an individual has two different sets of chromosomes in their body. This condition, often referred to as a form of true hermaphroditism, results from the presence of both ovarian and testicular tissue or hybrid characteristics. The term 'chimera' originates from Greek mythology, describing a creature made of different animals, and in medical terms, it refers to an organism composed of genetically distinct cells. This condition is classified under ICD-10 code Q99.0 and can manifest in various physical and reproductive features, making each case unique.
Causes & Symptoms
Clinical Causes: The primary cause of chimera 46, XX/XY is the abnormal fusion of two fertilized eggs (zygotes) early in development. Incomplete separation or fusion of two different embryonic cell lines results in an individual with two distinct sets of chromosomes. Genetic mutations or environmental factors during early pregnancy may influence the formation of chimeras.
Key Symptoms: Ambiguous genitalia or physical features that do not fit typical male or female categories. Presence of both ovarian and testicular tissue, which may be observed during medical examinations or surgeries. Differences in secondary sexual characteristics depending on the distribution of gonadal tissue. Possible hormonal imbalances affecting development and physical features. In some cases, subtle or no external signs, with diagnosis made through genetic testing. Potential fertility issues or reproductive anomalies.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chimera 46, XX/XY involves a combination of clinical evaluation and laboratory testing, including: - Karyotyping: analyzing chromosomes from blood or tissue samples to identify the mixed cell lines. - Hormonal assessments: measuring levels of sex hormones to understand gonadal function. - Imaging studies: ultrasounds or MRI scans to examine reproductive organs. - Biopsy or surgical sampling: to assess gonadal tissue if necessary. - Genetic counseling: providing information and support for affected individuals and their families.
Treatment Protocols: Management strategies are tailored to the individual's specific physical features and reproductive health needs: - Surgical interventions: to correct or remove abnormal gonadal tissue or genital structures as needed. - Hormone therapy: to develop secondary sexual characteristics or address hormonal imbalances. - Psychological support: counseling to assist with psychosocial challenges related to gender identity or physical appearance. - Fertility treatments: options depending on the extent of gonadal development and function. - Ongoing medical monitoring: regular evaluations to manage health concerns related to the condition. Since every case is unique, treatment plans are developed collaboratively by a team of specialists including endocrinologists, geneticists, gynecologists, urologists, and mental health professionals.
Clinical Advice & FAQs
Billing Guidance
Is Q99.0 a billable ICD-10 code?
Yes, Q99.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q99.0?
Clinical documentation must specify the nature of Chimera 46, XX/46, XY and any associated comorbidities for accurate reporting.
Cite this Clinical Reference